$IVA

$3.69 +$0.02 (0.68%) Close

$IVA Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 193.2M shares outstanding

Who owns IVA?

By type of holder

Institutions 43.8% Everyone else 56.2%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 10 holders own 51.0%

Srinivas Akkaraju 7.0% · Lampert Mark N 5.0%

Institutional ownership

43.8%

+16.7 pts vs last qtr

Institutional holders

+23 vs last qtr

Net shares bought

+32.3M

by institutions in Q2 2026

New / sold out

31 / 8

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Caligan Partners LP +3.2M
Nantahala Capital Management, LLC NEW +2.7M

Biggest sellers in Q2 2026

SymBiosis Capital Partners, LLC SOLD OUT −2.4M
RTW Investments, LP SOLD OUT −1.3M

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Inventiva SA in the last 12 months.

Is your stake being diluted?

There are not yet two fiscal years of reported share counts for Inventiva SA.

How patient are the owners?

Institutional shares by how long they've been held

5+ years3% 3–5 years0% 1–3 years4% Under 1 year94%

Quarterly turnover

42.2%

of institutional shares changed hands

Top 10 managers, median time held

2 quarters

Super Investors

Investment managers reporting IVA on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
CP Caligan Partners LP	8.2M	4.22%	+3.2M (+64.1%)	Q4 '25	1.5%
Shares held by quarter Peak holding8.2M (Q2'26) Change over 8 quarters+8.2M Share of the company4.220% Caligan Partners LP's full portfolio →
SB Samsara Biocapital, LLC	6.3M	3.27%	+1.1M (+21.6%)	Q4 '25	2.0%
Shares held by quarter Peak holding6.3M (Q2'26) Change over 8 quarters+6.3M Share of the company3.270% Samsara Biocapital, LLC's full portfolio →

Caligan Partners LP

8.2M

% of company

4.22%

Change vs last qtr

+3.2M (+64.1%)

Held since

Q4 '25

Samsara Biocapital, LLC

6.3M

% of company

3.27%

Change vs last qtr

+1.1M (+21.6%)

Held since

Q4 '25

28 more super investors behind a free account

See every manager holding Inventiva SA, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting IVA on Form N-PORT; together they hold 2.7% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
AW abrdn World Healthcare Fund abrdn World Healthcare Fund	$4.59M	1.2M	0.63%	0.81%	June 30, 2026
FB Franklin Biotechnology Discovery Fund Franklin Strategic Series	$4.55M	1.0M	0.53%	0.39%	July 31, 2026

abrdn World Healthcare Fund

Position value

$4.59M

% of company

0.63%

% of the fund

0.81%

As of

June 30, 2026

Franklin Biotechnology Discovery Fund

Franklin Strategic Series

Position value

$4.55M

% of company

0.53%

% of the fund

0.39%

As of

July 31, 2026

16 more funds behind a free account

See every fund holding Inventiva SA and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SA Srinivas Akkaraju 5%+ holder 13D · 7.4%	13.5M	7.01%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company7.010% Disclosed stake13D · 7.4% View the 13D/G filing →
LM Lampert Mark N 5%+ holder 13D · 5.0%	9.6M	4.95%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company4.950% Disclosed stake13D · 5.0% View the 13D/G filing →

Srinivas Akkaraju

5%+ holder13D · 7.4%

13.5M

% of company

7.01%

Change vs last qtr

—

Held since

—

Lampert Mark N

5%+ holder13D · 5.0%

9.6M

% of company

4.95%

Change vs last qtr

—

Held since

—

29 more holders behind a free account

See every insider and 5%+ holder of Inventiva SA.

Comments